Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
06 05 2020
Historique:
received: 20 12 2019
revised: 04 03 2020
pubmed: 13 3 2020
medline: 21 5 2021
entrez: 13 3 2020
Statut: ppublish

Résumé

Annelated purinedione derivatives have been shown to act as possible multiple-target ligands, addressing adenosine receptors and monoaminooxidases. In this study, based on our previous results, novel annelated pyrimido- and diazepino[2,1-f]purinedione derivatives were designed as dual-target-directed ligands combining A

Identifiants

pubmed: 32162782
doi: 10.1002/cmdc.201900717
doi:

Substances chimiques

Monoamine Oxidase Inhibitors 0
Neuroprotective Agents 0
Receptor, Adenosine A2A 0
Xanthines 0
Monoamine Oxidase EC 1.4.3.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

772-786

Informations de copyright

© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

WHO, World Report on Ageing and Health, 2015. https://www.who.int/ageing/publications/world-report-2015/en/.
A. K. Kakkar, N. Dahiya, Eur. J. Pharmacol. 2015, 750, 74-81.
M. E. Freitas, S. H. Fox, Neurodegener. Dis. 2016, 6, 249-268.
T. J. Wenzel, A. Klegeris, Life Sci. 2018, 207, 314-322.
M. B. H. Youdim, L. Kupershmidt, T. Amit, O. Weinreb, Parkinsonism Relat. Disord. 2014, 20, S132-S136.
W. J. Geldenhuys, C. J. Van der Schyf, Expert Opin. Drug Discovery 2013, 8, 115-129.
L. Pisani, M. Catto, F. Leonetti, O. Nicolotti, A. Stefanachi, F. Campagna, A. Carotti, Curr. Med. Chem. 2011, 18, 4568-4587.
A. Cavalli, M. L. Bolognesi, A. Mìnarini, M. Rosini, V. Tumiatti, M. Recanatini, C. Melchiorre, J. Med. Chem. 2008, 51, 347-372.
B. Mathew, D. G. T. Parambi, G. E. Mathew, M. S. Uddin, S. T. Inasu, H. Kim, A. Marathakam, M. K. Unnikrishnan, S. Carradori, Arch. Pharm. 2019, 352, 1-13.
J. P. Petzer, N. Castagnoli, M. a Schwarzschild, J. Chen, Neurotherapeutics 2009, 6, 141-151.
A. Stößel, M. Schlenk, S. Hinz, P. Küppers, J. Heer, M. Gütschow, C. E. Müller, J. Med. Chem. 2013, 56, 4580-4596.
M. Jaiteh, A. Zeifman, M. Saarinen, P. Svenningsson, J. Bréa, M. Isabel Loza, J. Carlsson, J. Med. Chem. 2018, 61, 5269-5278.
S. Aoyama, H. Kase, E. Borrelli, J. Neurosci. 2000, 20, 5848-5852.
B. C. Shook, P. F. Jackson, ACS Chem. Neurosci. 2011, 2, 555-567.
G. Navarro, A. Cordomí, V. Casadó-Anguera, E. Moreno, N.-S. Cai, A. Cortés, E. I. Canela, C. W. Dessauer, V. Casadó, L. Pardo, C. Lluís, S. Ferré, Nat. Commun. 2018, 9, 1242.
M. Rivera-Oliver, M. Díaz-Ríos, Life Sci. 2014, 101, 1-9.
C. Laurent, S. Eddarkaoui, M. Derisbourg, A. Leboucher, D. Demeyer, S. Carrier, M. Schneider, M. Hamdane, C. E. Müller, L. Buée, D. Blum, Neurobiol. Aging 2014, 35, 2079-2090.
A. Pinna, N. Simola, L. Frau, M. Morelli, in Adenosine, Springer New York, New York, NY, 2013, pp. 361-384.
P. Hickey, M. Stacy, Curr. Neurol. Neurosci. Rep. 2012, 12, 376-385.
F. F. Ribeiro, S. Xapelli, C. Miranda-Lourenço, S. R. Tanqueiro, J. Fonseca-Gomes, M. J. Diógenes, J. A. Ribeiro, A. M. Sebastião, Neuropharmacology 2016, 104, 226-242.
M. Kolahdouzan, M. J. Hamadeh, CNS Neurosci. Ther. 2017, 23, 272-290.
M. D. Mertens, S. Hinz, C. E. Müller, M. Gütschow, Bioorg. Med. Chem. 2014, 22, 1916-1928.
B. Strydom, J. J. Bergh, J. P. Petzer, Eur. J. Med. Chem. 2011, 46, 3474-3485.
M. B. H. Youdim, Y. S. Bakhle, Br. J. Pharmacol. 2009, 147, S287-S296.
J.-F. Chen, Y. Chern, Methylxantines, Springer, Berlin, Heidelberg, 2011, 267-310.
V. Flaten, C. Laurent, J. E. Coelho, U. Sandau, V. L. Batalha, S. Burnouf, M. Hamdane, S. Humez, D. Boison, L. V. Lopes, L. Buée, D. Blum, Biochem. Soc. Trans. 2014, 42, 587-592.
R. Dungo, E. D. Deeks, Drugs 2013, 73, 875-882.
S. Rivara, G. Piersanti, F. Bartoccini, G. Diamantini, D. Pala, T. Riccioni, M. A. Stasi, W. Cabri, F. Borsini, M. Mor, G. Tarzia, P. Minetti, J. Med. Chem. 2013, 56, 1247-1261.
P. Koch, R. Akkari, A. Brunschweiger, T. Borrmann, M. Schlenk, P. Küppers, M. Köse, H. Radjainia, J. Hockemeyer, A. Drabczyńska, K. Kieć-Kononowicz, C. E. Müller, Bioorg. Med. Chem. 2013, 21, 7435-7452.
M. Załuski, J. Schabikowski, M. Schlenk, A. Olejarz-Maciej, B. Kubas, T. Karcz, K. Kuder, G. Latacz, M. Zygmunt, D. Synak, S. Hinz, C. E. Müller, K. Kieć-Kononowicz, Bioorg. Med. Chem. 2019, 27, 1195-1210.
M. Załuski, K. Stanuch, T. Karcz, S. Hinz, G. Latacz, E. Szymańska, J. Schabikowski, A. Doroż-Płonka, J. Handzlik, A. Drabczyńska, C. E. Müller, K. Kieć-Kononowicz, MedChemComm 2018, 9, 951-962.
A. Drabczyńska, M. Zygmunt, J. Sapa, B. Filipek, C. E. Müller, K. Kieć-Kononowicz, Arch. Pharm. 2011, 344, 20-27.
K.-N. Klotz, M. J. Lohse, U. Schwabe, G. Cristalli, S. Vittori, M. Grifantini, Naunyn-Schmiedeberg′s Arch. Pharmacol. 1989, 340, 679-683.
C. E. Müller, J. Maurinsh, R. Sauer, Eur. J. Pharm. Sci. 2000, 10, 259-265.
T. Borrmann, S. Hinz, D. C. G. Bertarelli, W. Li, N. C. Florin, A. B. Scheiff, C. E. Müller, J. Med. Chem. 2009, 52, 3994-4006.
C. E. Müller, M. Diekmann, M. Thorand, V. Ozola, Bioorg. Med. Chem. Lett. 2002, 12, 501-503.
G. Latacz, A. S. Hogendorf, A. Hogendorf, A. Lubelska, J. M. Wierońska, M. Woźniak, P. Cieślik, K. Kieć-Kononowicz, J. Handzlik, A. J. Bojarski, MedChemComm 2018, 9, 1882-1890.
G. Latacz, A. Lubelska, M. Jastrzębska-Więsek, A. Partyka, M. A. Marć, G. Satała, D. Wilczyńska, M. Kotańska, M. Więcek, K. Kamińska, A. Wesołowska, K. Kieć-Kononowicz, J. Handzlik, Int. J. Mol. Sci. 2019, 20, 3420.
G. Latacz, A. Lubelska, M. Jastrzębska-Więsek, A. Partyka, A. Sobiło, A. Olejarz, K. Kucwaj-Brysz, G. Satała, A. J. Bojarski, A. Wesołowska, K. Kieć Kononowicz, J. Handzlik, Chem. Biol. Drug Des. 2017, 90, 1295-1306.
G. Latacz, A. Lubelska, M. Jastrzębska-Więsek, A. Partyka, K. Kucwaj-Brysz, A. Wesołowska, K. Kieć-Kononowicz, J. Handzlik, Bioorg. Med. Chem. Lett. 2018, 28, 878-883.
L. Smetanova, V. Stetinova, D. Kholova, J. Kvetina, J. Smetana, Z. Svoboda, Neuroendocrinol. Lett. 2009, 30, 101-105.
R. K. Y. Cheng, E. Segala, N. Robertson, F. Deflorian, A. S. Doré, J. C. Errey, C. Fiez-Vandal, F. H. Marshall, R. M. Cooke, Structure 2017, 25, 1275-1285.e4.
S. Weyler, F. Fülle, M. Diekmann, B. Schumacher, S. Hinz, K.-N. Klotz, C. E. Müller, ChemMedChem 2006, 1, 891-902.
E. Szymańska, A. Drabczyńska, T. Karcz, C. E. Müller, M. Köse, J. Karolak-Wojciechowska, A. Fruziński, J. Schabikowski, A. Doroz-Płonka, J. Handzlik, K. Kieć-Kononowicz, Bioorg. Med. Chem. 2016, 24, 4347-4362.
A. S. Doré, N. Robertson, J. C. Errey, I. Ng, K. Hollenstein, B. Tehan, E. Hurrell, K. Bennett, M. Congreve, F. Magnani, C.G. Tate, M. Weir, F.H. Marshall, Structure 2011, 19, 1283-1293.
C. Binda, J. Wang, L. Pisani, C. Caccia, A. Carotti, P. Salvati, D. E. Edmondson, A. Mattevi, J. Med. Chem. 2007, 50, 5848-52.
S.-Y. Son, J. Ma, Y. Kondou, M. Yoshimura, E. Yamashita, T. Tsukihara, Proc. Natl. Acad. Sci. USA 2008, 105, 5739-44.
P. Koch, R. Akkari, A. Brunschweiger, T. Borrmann, M. Schlenk, P. Küppers, M. Köse, H. Radjainia, J. Hockemeyer, A. Drabczyńska, K. Kieć-Kononowicz, C. E. Müller, Bioorg. Med. Chem. 2013, 21, 7435-7452.
A. Brunschweiger, P. Koch, M. Schlenk, F. Pineda, P. Küppers, S. Hinz, M. Köse, S. Ullrich, J. Hockemeyer, M. Wiese, J. Heer, C. E. Müller, ChemMedChem 2014, 9, 1704-1724.
K. K. Martin, J. L. Ulrich, G. Cristalli, S. Vittori, M. Grifantini, Naunyn Schmiedebergs Arch Pharmacol.1989, 679-683
R. K. Y. Cheng, E. Segala, N. Robertson, F. Deflorian, A. S. Doré, J. C. Errey, C. Fiez-Vandal, F. H. Marshall, R. M. Cooke, Structure 2017, 25, 1275-1285.e4.
Molecular Operating Environment (MOE), 2019.01; https://www.chemcomp.com/ (accessed 12. 12. 2019).
Schrödinger Release 2019-1: Schrödinger, LLC, New York, 2016.
K. S. Watts, P. Dalal, R. B. Murphy, W. Sherman, R. A. Friesner, J. C. Shelley, J. Chem. Inf. Model. 2010, 50, 534-546.
Schrödinger Release 2019-1: ConfGen, Schrödinger, LLC, New York, 2019.
Schrödinger Release 2019-1: Protein Preparation Wizard; Schrödinger, LLC, New York, 2019.
Schrödinger Release 2019-1: Glide, Schrödinger, LLC, New York, 2019.
M. Gidaro, F. Alcaro, S. Carradori, G. Costa, D. Vullo, C. Supuran, S. Alcaro, Planta Med. 2015, 81, 533-540.
Schrödinger Release 2019-1: Induced Fit Docking protocol; Glide, Schrödinger, LLC, New York, 2019; Prime, Schrödinger, LLC, New York, 2019.
E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. Ferrin, J. Comput. Chem. 2004, 25, 1605-1612.

Auteurs

Kamil J Kuder (KJ)

Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.

Michał Załuski (M)

Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.

Jakub Schabikowski (J)

Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.

Gniewomir Latacz (G)

Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.

Agnieszka Olejarz-Maciej (A)

Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.

Piotr Jaśko (P)

Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.

Agata Doroz-Płonka (A)

Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.

Andreas Brockmann (A)

PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry University of Bonn, An der Immenburg 4, 53121, Bonn, Germany.

Christa E Müller (CE)

PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry University of Bonn, An der Immenburg 4, 53121, Bonn, Germany.

Katarzyna Kieć-Kononowicz (K)

Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH